Koupit Retatrutide 64

RETATRUTIDE 64 is the double-strength pen in our metabolic line: the same triple-agonist compound acting on GLP-1, GIP and glucagon receptors, loaded at 64 mg instead of 32 mg in the same 3 mL cartridge.

It is built for people already past the introductory doses, where a 32 mg pen empties quickly and reordering becomes the bottleneck.

The clinical case for the compound is unchanged — what changes is cost and continuity. Twice the peptide per pen brings the price per milligram down and cuts the number of reorders across a titration.

Fewer shipments also means fewer cold-chain handovers, which is the point in a protocol where temperature excursions are most likely to occur.

This is not a higher dose per injection. Your weekly dose is dialled on the pen exactly as it is on the 32 mg pen — the cartridge simply holds more, so it lasts longer before replacement.

Because it carries more peptide, the 64 mg pen suits maintenance and upper-titration phases rather than a first cycle. If you are starting out, begin on the 32 mg pen and move up once your clinician has settled your dose.

Store the pen refrigerated between uses. Attach a fresh needle, dial your prescribed dose, press the button until the counter returns to zero, and hold for six seconds before withdrawing.

Most protocols run five days on, two days off — your printed dosing guide covers the exact schedule agreed with your clinician.